secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2024-09-23T23:59:59+00:00
Accession:  0001021771-24-000180
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative shareholders approve doubling of stock incentive plan shares to 6.85M
--------------------------------------------------------------------------------

- Class I director Nickolay Kukekov re-elected with 2,050,111 votes for, 135,114 withheld, 2,048,738 broker non-votes.
- Amendment to 2021 Stock Incentive Plan approved: 1,647,022 for, 518,921 against, 19,282 abstentions, 2,048,738 broker non-votes. Authorized shares increased from 3,850,000 to 6,850,000.
- Marcum LLP ratified as auditor for FY2024: 4,152,145 for, 18,696 against, 63,122 abstentions.
- Annual meeting held September 19, 2024; all three proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000180/0001021771-24-000180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000180/brt8k91924.htm
  HTML page:      https://secwatch.observer/filing/0001021771-24-000180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer